John L. Higgins
2013
In 2013, John L. Higgins earned a total compensation of $3M as President and Chief Executive Officer at Ligand Pharmaceuticals, a 27% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $375,248 |
|---|---|
| Option Awards | $1,567,129 |
| Salary | $500,331 |
| Stock Awards | $559,360 |
| Other | $2,843 |
| Total | $3,004,911 |
Higgins received $1.6M in option awards, accounting for 52% of the total pay in 2013.
Higgins also received $375.2K in non-equity incentive plan, $500.3K in salary, $559.4K in stock awards and $2.8K in other compensation.
Rankings
In 2013, John L. Higgins' compensation ranked 2,540th out of 12,286 executives tracked by ExecPay. In other words, Higgins earned more than 79.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,540 out of 12,286 | 79th |
Division Manufacturing | 836 out of 4,612 | 82nd |
Major group Chemicals And Allied Products | 223 out of 1,462 | 85th |
Industry group Drugs | 148 out of 1,156 | 87th |
Industry Pharmaceutical Preparations | 126 out of 890 | 86th |
Source: SEC filing on April 12, 2016.
Higgins' colleagues
We found four more compensation records of executives who worked with John L. Higgins at Ligand Pharmaceuticals in 2013.